Shi Si Pharmaceutical Group (02005.HK): Jia sulfa non-amine has been approved for registration as an active pharmaceutical ingredient for use in listed preparations.

Zhito Finance News APP, Sihuan Pharmaceutical Group (02005.HK) announced that the group's Levodopa Methyldopa has been approved and registered by the China National Medical Products Administration as a raw material for use in marketed formulations, making it the first domestic company to receive such approval. Levodopa Methyldopa is mainly used for the treatment of Parkinson's disease, and is used in combination with other Parkinson's medications such as Levodopa.